PMID- 18669440
OWN - NLM
STAT- MEDLINE
DCOM- 20080805
LR  - 20211020
IS  - 1533-4406 (Electronic)
IS  - 0028-4793 (Print)
IS  - 0028-4793 (Linking)
VI  - 359
IP  - 5
DP  - 2008 Jul 31
TI  - Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate.
PG  - 539-41
LID - 10.1056/NEJMc0804818 [doi]
FAU - Prins, Robert M
AU  - Prins RM
FAU - Cloughesy, Timothy F
AU  - Cloughesy TF
FAU - Liau, Linda M
AU  - Liau LM
LA  - eng
GR  - K01 CA111402-01A2/CA/NCI NIH HHS/United States
GR  - R01 CA123396-02/CA/NCI NIH HHS/United States
GR  - R01 CA123396/CA/NCI NIH HHS/United States
GR  - R01 CA112358-03/CA/NCI NIH HHS/United States
GR  - K01 CA111402/CA/NCI NIH HHS/United States
GR  - R01 CA112358/CA/NCI NIH HHS/United States
PT  - Case Reports
PT  - Clinical Trial, Phase I
PT  - Letter
PL  - United States
TA  - N Engl J Med
JT  - The New England journal of medicine
JID - 0255562
RN  - 0 (Cancer Vaccines)
SB  - IM
MH  - Brain Neoplasms/*therapy
MH  - *CD8-Positive T-Lymphocytes
MH  - Cancer Vaccines/*immunology/therapeutic use
MH  - Cytomegalovirus/*immunology
MH  - Cytomegalovirus Infections/*immunology
MH  - Dendritic Cells
MH  - Glioblastoma/*therapy
MH  - Humans
PMC - PMC2775501
MID - NIHMS77252
EDAT- 2008/08/02 09:00
MHDA- 2008/08/06 09:00
PMCR- 2009/11/10
CRDT- 2008/08/02 09:00
PHST- 2008/08/02 09:00 [pubmed]
PHST- 2008/08/06 09:00 [medline]
PHST- 2008/08/02 09:00 [entrez]
PHST- 2009/11/10 00:00 [pmc-release]
AID - 359/5/539 [pii]
AID - 10.1056/NEJMc0804818 [doi]
PST - ppublish
SO  - N Engl J Med. 2008 Jul 31;359(5):539-41. doi: 10.1056/NEJMc0804818.